Increased migration of neutrophils to granulocyte-colony stimulating factor in rat carrageenin-induced pleurisy: Roles of complement, bradykinin, and inducible cyclooxygenase-2

Inflammation Research

Volumn 45, Issue 7, 1996, Pages 335-346

  Ogino, M ^a   Majima, M ^a   Kawamura, M ^a   Hatanaka, K ^a   Saito, M ^a   Harada, Y ^a   Katori, M ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Complement; Cyclo oxygenase 2; Granulocyte colony stimulating factor; Kinin; Neutrophil migration

Indexed keywords

ACETYLSALICYLIC ACID; BRADYKININ; BROMELAIN; CARRAGEENAN; COBROTOXIN; COMPLEMENT; GRANULOCYTE COLONY STIMULATING FACTOR; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; ZYMOSAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CELL INFILTRATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; INFLAMMATORY INFILTRATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MONOCYTE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PLEURA FLUID; PLEURISY; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ASPIRIN; BRADYKININ; CAPILLARY PERMEABILITY; CARRAGEENAN; CELL MOVEMENT; COBRA VENOMS; COMPLEMENT SYSTEM PROTEINS; CYCLOOXYGENASE 2; DINOPROSTONE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; ISOENZYMES; MALE; MEMBRANE PROTEINS; NEUTROPHILS; PLEURISY; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; ZYMOSAN;

EID: 0030016865     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02252946     Document Type: Article

References (38)

1. Metcalf D. The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors. Blood 1986;67:257-74.
2. Souza LM, Boone TC, Gabrilove J, Lai PH, Zsebo KM, Murdoch DC, et al. Recombinant human colony-stimulating factor: Effects on normal and leukemic myeloid cells. Science 1986;232:61-5.
3. Nagata S, Tsuchiya M, Asano S, Kaziro Y, Yamazaki T. Yamamoto O, et al. Molecular cloning and expression of cDNA for human granulocytic colony-stimulating factor. Nature 1986;319:415-7.
4. Cohen AM, Zsebo KM, Inoue H, Hines D, Boone TC, Chazin VR, et al. In vivo stimulation of granulopoiesis by recombinant human granulocyte colony-stimulating factor. Proc Natl Acad Sci USA 1987;84:2484-8.
5. Shimamura M, Kobayashi Y, Tuo A, Urabe A, Okabe T, Komatu Y, et al. Effect of human recombinant granulocyte colony-stimulating factor on hematopoietic injury in mice induced by 5-fluorouracil. Blood 1987;69:353-5.
6. Weite K, Bonilla MA, Gillio AP, Boone TC. Potter GK, Gabrilove JL, et al. Recombinant human granulocyte colony-stimulating factor: Effects on hematopoiesis in normal and cyclophosphamide-treated primates. J Exp Med 1987;165:941-8.
7. Weite K, Bonilla MA, Gabrilove JL, Gillio AP, Potter GK, Moore MAS, et al. Recombinant human granulocyte colony-stimulating factor: In vitro and in vivo effects on myelopoiesis. Blood Cells 1987;13:17-30.
8. Bronchud MH, Scarffe JH, Thatcher N, Crowther D, Souza LM, Alton NK, et al. Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br J Cancer 1987;56:809-13.
9. Morstyn G, Campbell L, Souza LM, Alton NK, Keech J, Green M, et al. Effect of granulocyte colony-stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet 1988;1:667-71.
10. Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J, et al. Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 1988;318:1414-22.
11. Gabrilove JL, Jakubowski A, Fain K, Grous J, Scher H, Sternberg C, et al. Phase I study of granulocyte colony-stimulating factor in patients with transitional-cell carcinoma of the urothelium. J Clin Invest 1988;82:1454-61.
12. Di Rosa M. Biological properties of carrageenan. J Pharm Pharmac 1972;24:89-102.
13. Di Rosa M, Giroud JP, Willoughby DA. Studies of the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J Path 1971;104:15-29.
14. Vinegar R, Truax JF, Selph JL. Quantitative studies of the pathway to acute carrageenan inflammation. Fed Proc 1976;35:2447-56.
15. Vinegar R, Truax JF, Selph JL, Voelker FA. Pathway of onset, development, and decay of carrageenan pleurisy in rat. Fed Proc 1982;41:2588-95.
16. Uchida Y, Tanaka K, Harada Y, Ueno A, Katori M. Activation of plasma kallikrein-kinin system and its significant role in rat carrageenan-induced pleurisy. Inflammation 1983;7:121-31.
17. Majima M, Ueno A, Sunahara N, Katori M. Measurement of des-Phe-Arg9-bradykinin by enzyme immunoassay a useful parameter of plasma kinin release. In: Abe K, Moriya H, Fujii S, editors. New York: Plenum, 1989:535-40.
18. Katori M, Majima M, Harada Y, Ueno A. A significant role of plasma kallikrein-kinin system in plasma exudation of rat carrageenan-induced pleurisy. In: Abe K, Moriya H, Fujii S, editors. New York: Plenum, 1989: 137-44.
19. Majima M, Sunahara N, Harada Y, Katori M. Detection of the degradation products of bradykinin by enzyme immunoassays as markers for the release of kinin in vivo. Biochem Pharmacol 1993;45:559-67.
20. Oda T, Kojima Y, Akaike T, Ijiri S, Molla A, Maeda H. Inactivation of chemotactic activity of C5a by the serratial 56-kilodalton protease. Infect Immun 1990;58:1269-72.
21. Yonemoto K. Complement activation and leukocyte migration in rat carrageenin-induced pleurisy [In Japanese]. Jpn J Inflamm 1983;3:51-62.
22. Joiner KA, Hawiger A, Gelfand JA. The effect of cobra venom factor on alternative pathway hemolytic activity in mice. Immunol Commun 1980;9:277-81.
23. Ballow M, Cochrane CG. Two anticomplementary factors in cobra venom: Hemolysis of guinea pig erythrocytes by one of them. J Immunol 1969;103:944-52.
24. Cochrane CG, Mueller-Eberhart HJ, Aikin BS. Depletion of plasma complement in vivo by a protein of cobra venom: its effect of various immunologic reactions. J Immunol 1970;105:55-69.
25. Katori M, Kanayama T, Sasaki K, Ueno A, Takagi M, Yamashina S. Biphasic accumulation of leukocytes in rat cardiac infarct tissue caused by leukotriene B4 and complement. Jpn J Pharmacol 1989;50:234-8.
26. Oh-ishi S, Uchida Y, Ueno A, Katori M, Bromelain, a thiol-protease from pineapple stem, depletes high-molecular-weight kininogen by activation of Hageman factor (factor XII). Thromb Res 1979;14:665-72.
27. Majima M, Sunahara N, Harada Y, Katori M. Detection of the degradation products of bradykinin by enzyme immunoassays as markers for the release of kinin in vivo. Biochem Pharmacol 1993;45:559-67.
28. Suzuki Y, Harada Y, Ueno A, Katori M, Okabe H. Release of endogenous prostaglandins by mild hyperosmotic saline inhibits tetragastrin-stimulated gastric acid secretion in rats. Prostaglandins 1986;32:401-14.
29. Harada Y, Hatanaka K, Saito M, Majima M, Ogino M, Kawamura M, et al. Detection of inducible prostaglandin H synthase-2 in cells in the exudate of rat carrageenin-induced pleurisy. Biomed Res 1994;15:127-30.
30. Nahas N, Waterman WH, Sha'Afi RI. Granulocyte-macrophage colony-stimulating factor (GM-CSF) promotes phosphorylation and an increase in the activity of cytosolic phospholipase A2 in human neutrophils. Biochem J 1996;313:503-8.
31. Clark SC, Kamen R. The human hematopoietic colony-stimulating factor. Science 1987;236:1229-37.
32. Oda T, Katori M, Hatanaka K, Yamashina S. Five steps in leukocyte extravasation in the microcirculation by chemoattractants. Med Inflamm 1992;1:403-9.
33. Shima C, Majima M, Katori M. A stable metabolite of bradykinin, Arg-Pro-Pro-Gly-Phe, in the degradation in human plasma. Jpn J Pharmacol 1992;60:111-9.
34. Majima M, Shima C, Saito M, Kuribayashi Y, Katori M, Aoyagi T. Poststatin, a novel inhibitor of bradykinin-degrading enzymes in rat urine. Eur J Pharmacol 1993;232:181-90.
35. Harada Y, Tanaka K, Uchida Y, Ueno A. Oh-ishi S, Yamashita K, et al. Changes in the levels of prostaglandins and thromboxane and their roles in the accumulation of exudate in rat carrageenin-induced pleurisy - A profile analysis using gas chromatography-mass spectrometry. Prostaglandins 1982;23:881-96.
36. Katori M, Harada Y, Hatanaka K, Majima M, Kawamura M, Ohno T, et al. Induction of prostaglandin H synthase-2 in rat carrageenin-induced pleurisy and effect of a selective COX-2 inhibitor. Adv Prost Thromb Leukotr Res 1995;23: 345-7.
37. Harada Y, Hatanaka K, Saito M, Majima M, Ogino M, Kawamura M, et al. Cyclooxygenase-2 in the rat carrageenin-induced pleurisy. Jpn J Pharmacol 1995;67 Suppl I;72P.
38. Utsunomiya I, Nagai S, Oh-ishi S. Sequential appearance of IL-1 and IL-6 activities in rat carrageenin-induced pleurisy. J Immunol 1991;147:1803-9.